Sage Therapeutics Brass Sued Over Drug Candidate Claims

By Katryna Perera · May 14, 2025, 9:00 PM EDT

The top brass of Sage Therapeutics Inc. have been hit with a shareholder derivative suit in New York federal court alleging they misled investors about the safety, efficacy, durability and commercial...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Matton v. Greene et al

Case Number

1:25-cv-04017

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

May 13, 2025